Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top six pharmaceutical companies in India. Through our sales and marketing headquarters in Baltimore, MD, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies.
Post: Officer, Senior Officer, Executive
Applications are invited for the post of Junior Research Fellow (JRF) under SERB funded project entitled "Circadian resynchronization and nonalcoholic steatohepatitis: Role of Melatonin as a modifier."
Astral SteriTech Pvt. Ltd (formaly known as Astral Pharmaceutical Industries), symbolises dedication to quality, sincerity towards work and passion to achieve 100% customer satisfaction. ASTRAL SteriTech has carved its Niche as the specialized contract manufacturing company in the area of its core competence - Sterile Antibiotic Powder Injectable formulations. ASTRAL SteriTech is poised to explore the opportunities offered by the Global market for sterile antibiotic powder injectable formulations on the strength of its unique manufacturing facilities, Quality systems and trained human resource.
Post : Assistant Quality Assurance Manager
Inspired and moved to share below the essence of a true story which has unfolded in our own country in the recent past and in our own midst:
1. Which of the following trademarked sustained release systems are based on encapsulated drug particles that will dissolve at various rates ?
A) I only
B) III Only
C) I and II
D) I, II, and III
Candidates after submitting their applications through On-Line shall send photocopies of their all academic/required documents regarding their claims along with print out of On-Line application form within 21 days from the last date of submitting the applications (date 03rd October, 2016 till 5.00 O' Clock) on the working day through registered/Speed Post or Personally in the office of the Commission.
Zydus Hospira Oncology Private Limited (ZHOPL) is a 50%-50% joint venture (JV) company between Zydus Cadila. India and Hospira (a Pfizer company), manufacturing cytotoxic injectable products (Finished Products). With our past success in more than 30 regulatory inspections including USFDA. MHRA, PMDA. Japan etc... we now embark upon a journey of Self Reliant and making ZHOPL, a Centre of Excellence (CoE) for Oncology products.